Nanox Imaging Ltd. (NASDAQ: NNOX), a medical imaging technology company, announced that its Nanox.ARC X digital tomosynthesis system has been named one of TIME's Best Inventions of 2026. This recognition comes as the company prepares to showcase the system at the RSNA 2026 Annual Meeting in Chicago, signaling a significant step forward in its mission to expand access to advanced medical imaging.
The Nanox.ARC X is a U.S. Food and Drug Administration-cleared system that captures X-ray images from multiple angles, generating up to 200 coronal images per scan to produce three-dimensional views of the body at up to 80% less radiation than computed tomography (CT) for equivalent body parts. Designed with a smaller footprint than conventional CT systems, it operates using a standard 110-volt power outlet and features simplified installation, operator workflows, and remote upgrade capabilities. These attributes could make advanced imaging more accessible in a variety of healthcare settings, from hospitals to outpatient clinics, potentially improving early detection and patient outcomes.
This is not Nanox's first recognition from TIME; the company previously received a special mention on TIME's Best Inventions of 2024 list for its artificial intelligence imaging solutions. The latest honor underscores Nanox's ongoing commitment to innovation and its potential to disrupt the medical imaging market. For investors, the award may enhance the company's visibility and credibility, potentially attracting interest in its stock. For the healthcare industry, the Nanox.ARC X represents a promising alternative to traditional CT scanners, which are often expensive, bulky, and associated with higher radiation doses.
Nanox's broader ecosystem includes Nanox.ARC, Nanox.AI, Nanox.CLOUD, Nanox.MARKETPLACE, and Nanox Health IT, all aimed at driving the transition to preventive health care. By integrating affordable imaging hardware, AI-based solutions, cloud-based software, and remote radiology services, Nanox seeks to lower barriers to adoption and improve clinical efficiency. The recognition from TIME could accelerate these efforts by drawing attention to the company's vision and technologies.
For more information, the full press release is available at https://ibn.fm/wY1Fn. The latest news and updates relating to NNOX can be found in the company's newsroom at http://ibn.fm/NNOX. MissionIR, a specialized communications platform, assists IR firms with syndicated content to enhance visibility of private and public companies within the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions.
The implications of this announcement extend beyond a single award. As healthcare systems worldwide grapple with rising costs and the need for more efficient diagnostic tools, Nanox's technology could play a crucial role in making advanced imaging more accessible and affordable. The reduced radiation exposure also addresses growing concerns about patient safety, particularly for those requiring frequent scans. Moreover, the recognition from TIME may bolster Nanox's partnerships and adoption rates, as healthcare providers seek proven and innovative solutions. For investors, the award could serve as a catalyst for increased attention to NNOX, though it is essential to consider the competitive landscape and regulatory hurdles that lie ahead. Overall, the Nanox.ARC X's inclusion in TIME's Best Inventions of 2026 highlights the potential of digital tomosynthesis to redefine medical imaging standards and improve global health outcomes.
